Agomab Therapeutics NV - AGMB
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 8
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G | 4 |
| 6-K | 3 |
| SCHEDULE 13D | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | — | 0001172661-26-002216 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001104659-26-062718 | View |
| Apr 24, 2026 | 6-K | Apr 24, 2026 | 0001104659-26-048615 | View |
| Apr 16, 2026 | SCHEDULE 13G | — | 0001213900-26-044365 | View |
| Mar 06, 2026 | SCHEDULE 13G | — | 0000315066-26-000646 | View |
| Mar 05, 2026 | 6-K | Mar 05, 2026 | 0001104659-26-024095 | View |
| Feb 17, 2026 | SCHEDULE 13D | — | 0001193125-26-052946 | View |
| Feb 09, 2026 | 6-K | Feb 09, 2026 | 0001104659-26-012080 | View |